Geron Corporation
GERN US
GERN USGeron Corporation
United States CompositeCompany Description
- CEO
- Dr. John A. Scarlett M.D.
- Full Time Employees
- 141
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 919 East Hillsdale Boulevard Foster City CA United States 94404
- IPO Date
- Jul 31, 1996
- CIK
- 0000886744
- Website
- www.geron.com
- Business
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.